PAP Over Poppies

A team of researchers from Finland and the U.S. has shown that

prostatic acid phosphatase-a proteinonce used as a biomarker for prostate cancer-could be a better therapeutic agent than morphine for treating central neuropathic and chronic inflammatory pain. To harness the fullest therapeutic potential of prostatic acid phosphatase, researchers suggest developing a small molecule mimetic...